Cobalamin

DB14098ApprovedInvestigationalSmall molecule

Cobalamin: Overview.

Chemical structure of Cobalamin
Mechanism
Curator reviewed
Formula / weight
C62H88CoN13O14P · 1329.37 g/mol (avg)
First approval
Canada, 2005
Also known as
vitamin B12

Resolves to

Clinical / RWD
Structure
InChIKeyASARMUCNOOHMLO-WLORSUFZSA-LSMILES[Co++].[H]N([H])C(=O)CC[C@@H]1C2=N\C(=C(C)/C3=N[C@@](C)([C@]4([H])[N-]\C(=C(C)/C5=N/C(=C\2)/C(C)(C)[C@@H]5CCC(=O)N([H])[H])[C@](C)(CCC(=O)N([H])C[C@H](C)OP([O-])(=O)O[C@@H]2[C@@H](CO)O[C@@H]([C@@H]2O)N2C=NC5=C2C=C(C)C(C)=C5)[C@H]4CC(=O)N([H])[H])[C@@](C)(CC(=O)N([H])[H])[C@@H]3CCC(=O)N([H])[H])\[C@@]1(C)CC(=O)N([H])[H]

What you can answer from here — as of July 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
4TransportersSubstrate / inhibitor direction, not just membership
Listed above
1Drug interactionStructured to mechanism, not free text
Sign in
112Clinical trialsPhase, status and sponsor resolved per trial
Sign in
26Marketed productsAcross 2 countries and 15 labellers
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cobalamin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account